The Controversial History of Hormone Replacement Therapy

被引:129
作者
Cagnacci, Angelo [1 ]
Venier, Martina [1 ]
机构
[1] Azienda Sanit Univ Integrata, Obstet & Gynecol Unit, I-33100 Udine, Italy
来源
MEDICINA-LITHUANIA | 2019年 / 55卷 / 09期
关键词
hormone replacement therapy; osteoporosis; breast cancer; cardiovascular disease; BREAST-CANCER INCIDENCE; CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; ENDOMETRIAL CANCER; MEDROXYPROGESTERONE ACETATE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; FRACTURE INCIDENCE; RANDOMIZED-TRIAL;
D O I
10.3390/medicina55090602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The history of hormone replacement therapy (HRT) started in the 1960s, with very high popularity in the 1990s. The first clinical trials on HRT and chronic postmenopausal conditions were started in the USA in the late 1990s. After the announcement of the first results of the Women's Health Initiative (WHI) in 2002, which showed that HRT had more detrimental than beneficial effects, HRT use dropped. The negative results of the study received wide publicity, creating panic among some users and new guidance for doctors on prescribing HRT. The clear message from the media was that HRT had more risks than benefits for all women. In the following years, a reanalysis of the WHI trial was performed, and new studies showed that the use of HRT in younger women or in early postmenopausal women had a beneficial effect on the cardiovascular system, reducing coronary disease and all-cause mortality. Notwithstanding this, the public opinion on HRT has not changed yet, leading to important negative consequences for women's health and quality of life.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone
    Mueck, A. O.
    CLIMACTERIC, 2012, 15 : 11 - 17
  • [42] Hormone replacement therapy 2004 - The dilemma
    Flatau, E
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (10): : 642 - 642
  • [43] Cerebral embolism and hormone replacement therapy
    Inoue, N
    Kihara, K
    Hashiguchi, A
    Maehara, F
    Yoshioka, S
    Ushio, Y
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2001, 26 (03) : 181 - 186
  • [44] Hormone replacement therapy and cardiovascular disease
    Gupta, S
    Rymer, J
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 52 (02) : 119 - 125
  • [45] Unscheduled bleeding with hormone replacement therapy
    Dave, Fulva Gajjar
    Adedipe, Tolu
    Disu, Stewart
    Laiyemo, Raphael
    OBSTETRICIAN & GYNAECOLOGIST, 2019, 21 (02) : 95 - 101
  • [46] Angeliq® -: hormone replacement therapy with drospirenone
    Naftolin, F.
    CLIMACTERIC, 2007, 10 : 1 - 2
  • [47] Hormone replacement therapy and risk of malignancy
    Diamanti-Kandarakis, E
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2004, 16 (01) : 73 - 78
  • [48] Menopause and hormone replacement therapy.
    Tellier, P
    Godeau, P
    REVUE DE MEDECINE INTERNE, 2000, 21 (05): : 445 - 457
  • [49] Hormone replacement therapy and cervical cancer: a systematic review of the literature
    Vargiu, V.
    Amar, I. D.
    Rosati, A.
    Dinoi, G.
    Turco, L. C.
    Capozzi, V. A.
    Scambia, G.
    Villa, P.
    CLIMACTERIC, 2021, 24 (02) : 120 - 127
  • [50] Hormone replacement therapy (HRT), breast cancer and tumor pathology
    Dietel, Manfred
    MATURITAS, 2010, 65 (03) : 183 - 189